THE BEST SIDE OF ABBV-744 CLINICAL TRIAL PHASE 1 RESULTS

Added studies in progress propose that ARV-825 may additionally be effective in maximizing the reaction to estrogen deprivation (aromatase inhibition), another element of standard of treatment in ER+ breast cancer.Total, our latest work highlights the potential utilization of ARV-825 in combination with TAM. When ABBV-744 could also suppress prolif